Menu

Exterior shot of U.S. Supreme Court

Four insulin manufacturers have asked the U.S. Supreme Court to review a federal appeals court ruling that allowed a 340B antitrust class action lawsuit to proceed against them.

Insulin Drugmakers ask SCOTUS to Review 340B Antitrust Case After Appeals Court Denied Rehearing Request

March 24, 2026 Shannon Young, Associate Editor/Senior Writer 340B Report Views

Four major insulin manufacturers recently asked the U.S. Supreme Court to review a federal appeals court’s August ruling that allowed [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

House Members Circulate Letter to Ban 340B Rebate Model in Federal Funding Bill

Provider Groups Defend 340B After E&C Subcommittee Hearing